TY  - CONF
AU  - Gerards, Michelle
AU  - Hübner, Constanze
AU  - Baumeister, Annika
AU  - Ribaldi, Federica
AU  - Cantero-Fortiz, Yahveth
AU  - Braun, Julia
AU  - Boada, Mercè
AU  - Frisoni, Giovanni B
AU  - Schmitz-Luhn, Björn
AU  - Schwegler, Carolin
AU  - Woopen, Christiane
AU  - Jessen, Frank
AU  - Rostamzadeh, Ayda
TI  - The Role of Risk Perception and Psychosocial Factors in Attitudes and Views on Preclinical Dementia Risk Estimation – The PreTAD‐Study
JO  - Alzheimer's and dementia
VL  - 21
IS  - S3
SN  - 1552-5260
M1  - DZNE-2026-00007
SP  - e098147
PY  - 2025
AB  - Background:Advances in disease-modifying treatments and blood-based biomarkers for Alzheimer's disease (AD) have increased the importance of early diagnosis and dementia risk estimation before symptom onset. Autonomous decisions about AD risk estimation are complex and should align with individual needs and preferences. The PreTAD study (Predictive Turn in Alzheimer's Disease: Ethical, Clinical, Linguistic, and Legal Aspects) evaluates and compares attitudes on dementia risk estimation among first-degree relatives of individuals with dementia and patients with subjective cognitive decline to improve counseling for preclinical predictive AD diagnostics in the future.Method:PreTAD assesses risk perception, attitudes and views on AD dementia risk estimation, along with influencing psychosocial factors (living situation, loneliness, resilience, anxiety, and depression). The risk perception survey assessed participants’ opinions on two aspects: (1) what percentage they consider to represent a high general risk of developing AD dementia (perceived high general dementia risk), and (2) their perceived personal risk of developing AD dementia within 10 years (personal dementia risk).Result:Results from 390 participants in Germany, Switzerland, and Spain are presented. The perceived high general dementia risk assessed by participants ranged from >0
T2  - Alzheimer’s Association International Conference
CY  - 27 Jul 2025 - 31 Jul 2025, Toronto (Canada)
Y2  - 27 Jul 2025 - 31 Jul 2025
M2  - Toronto, Canada
LB  - PUB:(DE-HGF)1 ; PUB:(DE-HGF)16
DO  - DOI:10.1002/alz70857_098147
UR  - https://pub.dzne.de/record/283111
ER  -